Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Hyperaldosteronism × Observation × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 12 Neoplasms 11 Prostatic Neoplasms 10 Colorectal Neoplasms 9 Stomach Neoplasms 8 Pancreatic Neoplasms 7 Lung Neoplasms 6 Endometrial Neoplasms 5 Carcinoma, Hepatocellular 5 Sarcoma 3 Gastrointestinal Stromal Tumors 3 Gastrointestinal Neoplasms 3 Esophageal Neoplasms 3 Colorectal Neoplasms, Hereditary Nonpolyposis 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Small Cell Lung Carcinoma 2 Skin Neoplasms 2 Salivary Gland Neoplasms 2 Recurrence 2 Rectal Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Polycystic Ovary Syndrome 2 Peritoneal Neoplasms 2 Papillomavirus Infections 2 Ovarian Neoplasms 2 Obesity 2 Multiple Myeloma 2 Mouth Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2

Interventions

ziprasidone 1 Zolpidem 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Tobramycin 1 Staining and Labeling 1 Spironolactone 1 Sevelamer 1 Rocuronium 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1 Observation 1 Nifedipine 1 Nafcillin 1 Molindone 1 Methylprednisolone 1 Lurasidone Hydrochloride 1 Labetalol 1 Haloperidol 1 Fosfomycin 1 Clozapine 1 Ciprofloxacin 1 Cidofovir 1 Cefepime 1 Bosentan 1 Aminocaproic Acid 1 Amikacin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07272187 2025-12-09

EURAGIL

Herlev Hospital

Hyperaldosteronism, Insulinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡